OCULAR GENE THERAPY

Details for Australian Patent Application No. 2003277910 (hide)

Owner NOVARTIS AG

Inventors CAMPOCHIARO, Peter, Anthony; KALEKO, Michael

Pub. Number AU-A-2003277910

PCT Number PCT/EP03/10725

PCT Pub. Number WO2004/028635

Priority 60/414,048 27.09.02 US

Filing date 26 September 2003

Wipo publication date 19 April 2004

International Classifications

A61P 027/02 Drugs for disorders of the senses

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/414,048 27.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003277910

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003277911-STABILIZER-FREE STABILIZED COFFEE AROMA

2003277909-RECOMBINANT MVA STRAINS AS POTENTIAL VACCINES AGAINST P. FALCIPARUM MALARIA